Robert S. JANSSEN;DYNAVAX TECHNOLOGI;Svetlana SADEKOVA;David Ross KAUFMAN;Robert L. COFFMAN;Cristiana GUIDUCCI;MERCK SHARP & DOHME CORP.;Uyen truong PHAN;Ying YU;Andrew Evan DENKER;Robert A. KASTELEIN
发明人:
Ying YU,Andrew Evan DENKER,Svetlana SADEKOVA,Uyen Truong PHAN,Robert A. KASTELEIN,David Ross KAUFMAN,Robert L. COFFMAN,Cristiana GUIDUCCI,Robert S. JANSSEN
申请号：
US15577369
公开号：
US20180169229A1
申请日:
2016.05.26
申请国别(地区):
US
年份:
2018
代理人:
摘要：
The present disclosure describes combination therapies comprising an antagonist of Programmed Death 1 receptor (PD-1) and a Toll-like receptor 9 (TLR9) agonist that is a CpG-C type oligonucleotide, and the use of the combination therapies for the treatment of cancer.
